查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1468062

2024-2032 年按放射性核种类型、医疗应用、最终用户和地区分類的α发射体市场报告

Alpha Emitter Market Report by Type of Radionuclide, Medical Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球α辐射体市场规模达14.768亿美元。

阿尔法发射体是放射源发射的物质，在释放阿尔法粒子后会衰变。它们实现适当的生物分布和相关的剂量分布，以实现有效的治疗，而不会引起不可接受的急性或长期副作用。 α粒子具有极高的细胞杀伤率，在医疗过程中使用时比β粒子对肿瘤细胞更具破坏性。因此，它们对邻近正常组织造成的损害较小。镭、铅和铋是治疗过程中使用的一些放射性核种。 α粒子的短程和高线性能量转移（LET）使其对医学研究非常有吸引力，特别是作为一种可行的癌症治疗方法。有多种类型的癌症可以用α发射体治疗，包括卵巢癌、胰臟癌、淋巴瘤和黑色素瘤。

α发射体市场趋势：

该市场主要由癌症治疗领域进行的广泛高端研发（R&D）活动所推动。这可以归因于人们对目标α发射体的细胞杀伤能力的认识不断增强。与此一致的是，大众中各种类型癌症的盛行率不断上升，为市场提供了动力。此外，容易患多种心臟病和癌症疾病的老年人口不断增加，也为市场创造了积极的前景。此外，医疗机构越来越多地采用标靶抗癌或阿尔法疗法（TAT），正在对市场产生积极影响。持续的技术进步和越来越多的新核医学产品批准进一步推动了市场。影响市场的其他一些因素包括快速城市化、医疗基础设施的不断改善、医疗支出的增加以及个人可支配收入水准的提高。

本报告回答的关键问题

  • 2023 年全球 α 发射体市场规模有多大？
  • 2024-2032年全球α发射体市场的预期成长率是多少？
  • 推动全球阿尔法发射体市场的关键因素是什么？
  • COVID-19 对全球 α 发射体市场有何影响？
  • 根据放射性核种的类型，全球 α 发射体市场的划分是怎样的？
  • 基于医疗应用的全球阿尔法发射体市场的细分是什么？
  • 全球阿尔法发射体市场的关键区域有哪些？
  • 全球阿尔法发射体市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球α发射体市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：依放射性核种类型

  • 砈
    • 市场走向
    • 市场预测
  • 镭
    • 市场走向
    • 市场预测
  • 锟
    • 市场走向
    • 市场预测
  • 带领
    • 市场走向
    • 市场预测
  • 铋
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依医疗应用

  • 摄护腺癌
    • 市场走向
    • 市场预测
  • 骨转移
    • 市场走向
    • 市场预测
  • 卵巢癌
    • 市场走向
    • 市场预测
  • 胰腺癌
    • 市场走向
    • 市场预测
  • 内分泌肿瘤
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 医学研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Actinium Pharmaceuticals Inc.
    • Alpha Tau Medical Ltd.
    • Bayer AG
    • Fusion Pharmaceuticals
    • IBA RadioPharma Solutions
    • RadioMedix Inc.
Product Code: SR112024A6398

The global alpha emitter market size reached US$ 1,476.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 10,975.8 Million by 2032, exhibiting a growth rate (CAGR) of 24.22% during 2024-2032.

Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.

Alpha Emitter Market Trends:

The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global alpha emitter market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type of radionuclide, medical application, and end user.

Breakup by Type of Radionuclide:

Astatine

Radium

Actinium

Lead

Bismuth

Others

Breakup by Medical Application:

Prostate Cancer

Bone Metastasis

Ovarian Cancer

Pancreatic Cancer

Endocrine Tumors

Others

Breakup by End User:

Hospitals

Medical Research Institutions

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global alpha emitter market in 2023?
  • 2. What is the expected growth rate of the global alpha emitter market during 2024-2032?
  • 3. What are the key factors driving the global alpha emitter market?
  • 4. What has been the impact of COVID-19 on the global alpha emitter market?
  • 5. What is the breakup of the global alpha emitter market based on the type of radionuclide?
  • 6. What is the breakup of the global alpha emitter market based on the medical application?
  • 7. What are the key regions in the global alpha emitter market?
  • 8. Who are the key players/companies in the global alpha emitter market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alpha Emitter Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type of Radionuclide

  • 6.1 Astatine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radium
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Actinium
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lead
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Bismuth
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Medical Application

  • 7.1 Prostate Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bone Metastasis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ovarian Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Endocrine Tumors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Research Institutions
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Actinium Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Alpha Tau Medical Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Pharmaceuticals
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 IBA RadioPharma Solutions
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 RadioMedix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio

List of Figures

  • Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
  • Figure 2: Global: Alpha Emitter Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2023
  • Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2023
  • Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
  • Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
  • Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million US$), 2024-2032
  • Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million US$), 2024-2032
  • Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Alpha Emitter Market: Competitive Structure
  • Table 7: Global: Alpha Emitter Market: Key Players